Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldebain in Laparoscopic Bariatric Surgery
NCT04651361Phase 3Unknown
- Sponsor
- E-Da Hospital
- Start
- Jun 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinalbuphine sebacate in postoperative pain, chronic postsurgical pain (CPSP), sponsored by E-Da Hospital. Status: unknown.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative painchronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT04651361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04651361.